CLOs on the Move

QuVa Pharma, Inc

www.quvapharma.com

 
QuVa Pharma, Inc. is a newly-formed national platform for sterile compounding pharmacy services led by two experienced industry executives that has received a majority equity commitment from Bain Capital Private Equity to support the company’s creation and expansion plans. As part of its formation, QuVa Pharma has acquired the assets of the compounding services division of a company leader in the field of parenteral and management services, including its state-of-the-art 503B manufacturing facility in Sugar Land, Texas.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.quvapharma.com
  • 1075 W. Park One Drive Suite 100
    Sugar Land, TX USA 77478
  • Phone: 888.339.0874

Executives

Name Title Contact Details

Similar Companies

Seagate Alliance

Seagate Alliance is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Harlan Laboratories Inc

To the scientific community, the name Harlan has meant high quality animals for over 70 years. Howard P. Harlan foresaw the need for laboratory animals and founded the business in Indianapolis, Indiana, in 1931. From 1931 until the time of his death in

Great HealthWorks

Great HealthWorks is dedicated to providing exceptional, science-based health and wellness products with world class customer service.

DMC - PHO

DMC - PHO is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lantheus

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.